Immunovant

Website: Immunovant
Business Area(s): 
Description: 

Immunovant is a biopharmaceutical company committed to developing autoimmune disease therapies. Their primary investigational product candidate is IMVT-1401, a human recombinant anti-FcRn monoclonal antibody that is being developed with a focus on patient need, and may be applicable to a wide array of autoimmune diseases.

Location(s): 
Durham NC
United States
New York NY
United States
Basel
Switzerland